
How Lutetium-177 PSMA Therapy is Transforming Prostate Cancer Treatment
Lutetium-177 PSMA therapy, marketed as Pluvicto, marks a pioneering advancement in treating metastatic prostate cancer. This theranostic treatment not only targets cancer cells with precision through radiotracers but also minimizes damage to healthy tissue. As clinical trials unfold, there is promise for integrating this therapy as a first-line treatment, offering hope to those who have […]
3 minute read